指南与共识腹部CTMRUS

从发病机制到风险评估理解导管内乳头状黏液性肿瘤:基于京都指南的图解综述

Understanding intraductal papillary mucinous neoplasm from pathogenesis to risk assessment: a pictorial review based on the kyoto guidelines.
指南 / 共识 · Abdom Radiol (NY) · 2025-06-16

本文基于修订后的京都指南,综述导管内乳头状黏液性肿瘤(IPMN)的影像相关要点与病理背景,阐述解剖位置、组织学亚型与异型增生程度三套分类系统的关联,讨论两种癌变模式、高风险征象与担忧特征、鉴别诊断、管理流程与监测方法,强调高风险征象虽为高级别异型增生或浸润癌的强预测因子,但手术决策应个体化。

要点

  • IPMN分为分支胰管型、主胰管型和混合型,影像风险评估须结合解剖分型与组织学亚型。
  • 高风险征象为高级别异型增生或浸润癌的强预测因子,担忧特征用于风险分层。
  • 手术决策应个体化,综合考虑患者意愿、合并症与预期寿命。

核心结论

  • 高风险征象是高级别异型增生或浸润癌的强预测因子,但手术决策应个体化,综合考虑患者意愿、合并症与预期寿命。

研究设计与样本

  • 基于京都指南的图解综述,系统回顾IPMN从发病机制到风险评估的影像与病理相关内容。

关键影像表现/征象

  • IPMN按解剖位置分为分支胰管型、主胰管型和混合型,按组织学亚型分为胃型、肠型和胰胆管型,按异型增生程度分为低级别、高级别异型增生或伴浸润癌。
  • IPMN存在两种不同癌变模式:序贯模式导致与IPMN相关的高级别异型增生或浸润癌,伴同模式导致在携带IPMN的胰腺中发生胰腺导管腺癌。
  • 文中提供高风险征象与担忧特征的图解示例,并强调潜在的诊断陷阱。

诊断标准与关键数值

  • 高风险征象与担忧特征用于指导IPMN风险分层。
  • 解剖位置、组织学亚型与异型增生程度三套分类系统相互关联,是影像风险评估与临床决策的基础。

临床应用与阅片要点

  • 阅片时应结合解剖分型、组织学亚型与异型增生程度进行综合风险评估。
  • 需注意与浆液性囊性肿瘤、黏液性囊性肿瘤、胰腺上皮内瘤变、假性囊肿及大导管型胰腺导管腺癌的鉴别。
  • 应参照京都指南推荐的管理流程与监测方法进行随访。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Intraductal papillary mucinous neoplasm (IPMN) is the most common cystic neoplasm of the pancreas, encompassing a spectrum from benign to malignant lesions. Recently, the international guidelines for IPMN management were revised as the Kyoto guidelines, emphasizing the critical role of imaging in diagnosis, risk assessment, and surveillance. This article provides a comprehensive review of IPMN based on the updated guidelines, focusing on imaging-related aspects while elucidating the underlying pathological background. We present the three interrelated classification systems for IPMN: anatomical location (branch-duct, main-duct, or mixed type), histological subtype (gastric, intestinal, or pancreatobiliary), and degree of dysplasia (low-grade, high-grade, or associated invasive carcinoma). Understanding these classifications and their correlations is fundamental for imaging-based risk assessment and clinical decision-making. We discuss the two distinct carcinogenesis patterns in IPMN-sequential pattern resulting in high-grade dysplasia or invasive carcinoma associated with IPMN, and concomitant pattern leading to pancreatic ductal adenocarcinoma in IPMN-harboring pancreas. The article reviews high-risk stigmata and worrisome features that guide risk stratification, providing illustrative examples and highlighting potential diagnostic pitfalls. We also examine differential diagnoses including serous cystic neoplasm, mucinous cystic neoplasm, pancreatic intraepithelial neoplasia, pseudocysts, and large duct type pancreatic ductal adenocarcinoma. Finally, we review the current management algorithm and surveillance methods recommended by the Kyoto guidelines. This review aims to enhance radiologists' and clinicians' understanding of IPMN by integrating pathological knowledge with imaging findings, emphasizing that while high-risk stigmata are strong predictors of high-grade dysplasia or invasive carcinoma, surgical decisions should be individualized considering multiple factors including patient preferences, comorbidities, and life expectancy.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Tashiro Y, Kachi M, Hashimoto T, et al. Understanding intraductal papillary mucinous neoplasm from pathogenesis to risk assessment: a pictorial review based on the kyoto guidelines. Abdom Radiol (NY). 2025. PMID: 40522384. doi:10.1007/s00261-025-04996-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。